The weekly litigation news digest is live. Subscribe now

IP Verse

Engineered Natural Killer Cells And Uses Thereof - EP3895712

The patent EP3895712 was granted to ONK Therapeutics on Jun 22, 2022. The application was filed on Dec 11, 2017 under application number EP21160170A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3895712

ONK THERAPEUTICS
Application Number
EP21160170A
Filing Date
Dec 11, 2017
Status
Granted And Under Opposition
May 20, 2022
Publication Date
Jun 22, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
AMMELBURGMar 21, 2023FISH & RICHARDSON PCADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2006099875
DESCRIPTIONWO2009077857
DESCRIPTIONWO2011154453
OPPOSITIONCN105384825
OPPOSITIONUS2009285799
OPPOSITIONUS2010092489
OPPOSITIONWO2011154453
OPPOSITIONWO2014138704
OPPOSITIONWO2015142675
OPPOSITIONWO2016102687
OPPOSITIONWO2016109668
OPPOSITIONWO2016126608
OPPOSITIONWO2016201394
OPPOSITIONWO2016210293
OPPOSITIONWO2017017184
OPPOSITIONWO2017025038
OPPOSITIONWO2018104562

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents